Chinese Multiple Dose Escalation (MDE) High Dose Study
Status:
Recruiting
Trial end date:
2022-11-30
Target enrollment:
Participant gender:
Summary
A Phase 1 Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety,
Tolerability, Pharmacokinetics, and Efficacy of Cotadutide in Overweight/Obese Subjects with
Chinese ancestry with Type 2 Diabetes Mellitus